Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy

Integrase-defective lentiviral vectors (IDLVs) have been used as a safe and efficient delivery system in several immunization protocols in murine and non-human primate preclinical models as well as in recent clinical trials. In this work, we validated in preclinical murine models our vaccine platfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Morante, Valeria, Borghi, Martina, Farina, Iole, Michelini, Zuleika, Grasso, Felicia, Gallinaro, Alessandra, Cecchetti, Serena, Di Virgilio, Antonio, Canitano, Andrea, Pirillo, Maria Franca, Bona, Roberta, Cara, Andrea, Negri, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927015/
https://www.ncbi.nlm.nih.gov/pubmed/33672349
http://dx.doi.org/10.3390/v13020355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927015/
https://www.ncbi.nlm.nih.gov/pubmed/33672349
http://dx.doi.org/10.3390/v13020355

Ejemplares similares